| 1 | 3057-04-3 | METHYL CHENODEOXYCHOLATE | C25H42O4 | 406.6 | 85-94 °C | |
| 2 | 3057-08-7 | 5,5-dimethyl-2-phenoxy-1,3,2-dioxaphosphorinane | C11H15O3P | 226.21 | | |
| 3 | 3057-45-2 | 1,4-Phenylenedimethanamine dihydrochloride | C8H14Cl2N2 | 209.11616 | | |
| 4 | 3057-74-7 | H-Asp(OtBu)-OH | C8H15NO4 | 189.21 | 220°C (dec.) | |
| 5 | 3057-91-8 | spiro[3.3]heptane-2,6-dicarboxylic acid | C9H12O4 | 184.19 | 230-235℃ | |
| 6 | 3057053-17-2 | Glutarylcarnitine-d3 chloride | C31H28D3F3N8O4 | 639.64 | | |
| 7 | 3057054-81-3 | tert-butyl ((1R,3R)-3-(6-chloro-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)cyclopentyl)carbamate | | | | |
| 8 | 3057054-82-4 | 1-((1R,3R)-3-aminocyclopentyl)-6-chloro-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one | | | | |
| 9 | 3057054-83-5 | methyl ((1R,3R)-3-(6-chloro-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)cyclopentyl)carbamate | | | | |
| 10 | 3057055-54-3 | methyl ((1R,3R)-3-(6-chloro-3-(methyl-d3)-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]pyridin-1-yl)cyclopentyl)carbamate | | | | |
| 11 | 3057092-65-3 | hOAT-IN-1 | | | | |
| 12 | 3057097-31-8 | A13:B7-24-GG | | | | |
| 13 | 30571-54-1 | Ribose tetracetate | C13H18O9 | 318.28 | 110 °C | |
| 14 | 30571-56-3 | SYRUP | C13H18O9 | 318.28 | | |
| 15 | 30571-58-5 | L-Fucose tetraacetate | C14H20O9 | 332.3 | | |
| 16 | 30571-71-2 | 3-BROMODECANE | C10H21Br | 221.18 | | |
| 17 | 30571-72-3 | 6-Chloro-1-ethyloctyl(methyl) ether | C11H23ClO | 206.75 | | |
| 18 | 30571-73-4 | 1-Ethyloctylmethyl sulfide | C11H24S | 188.37 | | |
| 19 | 30571-74-5 | 8-Methoxy-3-decanol | C11H24O2 | 188.31 | | |
| 20 | 30571-77-8 | 3-Methoxy-8-(methylthio)decane | C12H26OS | 218.4 | | |
| 21 | 30571-79-0 | 3-Decanone, 8-methoxy- | C11H22O2 | 186.29 | | |
| 22 | 30571-80-3 | 2-Ethyl-2-(5-methoxyheptyl)-1,3-dioxolane | C13H26O3 | 230.34 | | |
| 23 | 30571-99-4 | Glucopyranoside, methyl6-bromo-6-deoxy-, 2,3-dibenzoate 4-methanesulfonate, a-D- (8CI) | C22H23BrO9S | 543.38162 | | |
| 24 | 3057162-90-7 | methyl 2-((3S,10aS)-1,4-dioxo-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indol-3-yl)acetate | C14H14N2O4 | 274.27 | | |
| 25 | 3057176-00-5 | EP-3945 | | | | |
| 26 | 3057188-69-6 | 7-(2-chloro-6-fluorophenyl)-2-phenylbenzo[d]oxazole | | | | |
| 27 | 30572-00-0 | Glucopyranoside, methyl6-deoxy-6-iodo-, 2,3-dibenzoate 4-methanesulfonate, a-D- (8CI) | C22H23IO9S | 590.38 | | |
| 28 | 30572-01-1 | Galactopyranoside,methyl 4,6-dibromo-4,6-dideoxy-, dibenzoate, a-D- (8CI) | C21H20Br2O6 | 528.1879 | | |
| 29 | 30572-25-9 | Benzyl 2-O,3-O-isopropylidene-α-D-mannofuranoside 6-methanesulfonate | C17H24O8S | 388.43 | | |
| 30 | 30572-42-0 | (2S,3R,4S,5S,6R)-2-(4-bromophenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol | C12H15BrO6 | 335.15 | | |
| 31 | 30572-91-9 | DL-P-CHLOROMETHAMPHETAMINEHYDROCHLORIDE CRYSTALLIN | C10H15Cl2N | 220.1388 | | |
| 32 | 30572-96-4 | 1,2-Cyclodecanediol, (1R,2S)-rel- | C10H20O2 | 172.26 | | |
| 33 | 3057206-40-0 | PAR4 antagonist 3 | | | | |
| 34 | 3057206-41-1 | PAR4 antagonist 4 | | | | |
| 35 | 3057221-35-6 | 1H-Pyrrolizine-7a(5H)-carboxylic acid, 2-chlorotetrahydro-, methyl ester | C9H14ClNO2 | 203.67 | | |
| 36 | 3057263-82-5 | CK1δ-IN-9 | | | | |
| 37 | 3057270-84-2 | Estrogen receptor β/HDAC probe 1 | | | | |
| 38 | 3057274-61-7 | COX-2/NLRP3-IN-1 | | | | |
| 39 | 30573-52-5 | 2-(2-ETHYLANILINO)ETHANOL | C10H15NO | 165.23 | | |
| 40 | 30573-88-7 | 3-(2-CHLORO-PHENYL)-PROPIONIC ACID ETHYL ESTER | C11H13ClO2 | 212.67272 | | |
| 41 | 30574-44-8 | 2,6-dimethylocta-2,7-dienyl acetate | C12H20O2 | 196.29 | | |
| 42 | 30574-97-1 | (E)-2-methyl-2-butenenitrile | C5H7N | 81.12 | | |
| 43 | 3057447-11-4 | (S,R,S)-AHPC-CO-PEG-C2-iodine | | | | |
| 44 | 3057478-36-8 | WML-01 | | | | |
| 45 | 30575-73-6 | 1H-Indene-1,3(2H)-dione, 4,5,6,7-tetrabromo- | C9H2Br4O2 | 461.73 | | |
| 46 | 30575-79-2 | Coumarin, 3,6,7-trihydroxy-4-methyl- (8CI) | C10H8O5 | 208.17 | | |
| 47 | 30575-95-2 | (4-bromophenyl)(2'-phenyl-1(2H)-oxospiro[acenaphthylene-2,3'-cycloprop]-1'-yl)methanone | C27H17BrO2 | 453.32668 | | |
| 48 | 3057507-76-0 | 7-Fluoro-5-methyl-1H-indazol-4-amine | | | | |
| 49 | 3057532-78-9 | DAPK1 ligand-1 | | | | |
| 50 | 3057544-36-9 | methyl 4-carbamoyl-2-oxabicyclo[2.2.2]octane-1-carboxylate | | | | |
| 51 | 3057544-65-4 | Vem-L-Cy5 | | | | |
| 52 | 30576-26-2 | 2-Furancarboxaldehyde, 5-nitro-, 2-[4-(dimethylamino)-6-(trichloromethyl)-1,3,5-triazin-2-yl]hydrazone | C11H10Cl3N7O3 | 394.6 | | |
| 53 | 30576-27-3 | 1,3,5-Triazin-2-amine, 4-(dichloromethyl)-6-methyl- | C5H6Cl2N4 | 193.03 | | |
| 54 | 30576-30-8 | 1,3,5-Triazin-2-amine, N-hexyl-4-(methylthio)-6-(trichloromethyl)- | C11H17Cl3N4S | 343.7 | | |
| 55 | 30576-31-9 | 1,3,5-Triazin-2-amine, 4-[(2,4-dichlorophenyl)thio]-6-(trichloromethyl)- | C10H5Cl5N4S | 390.5 | | |
| 56 | 30576-32-0 | 1,3,5-Triazin-2-amine, 4,6-diethoxy- | C7H12N4O2 | 184.2 | | |
| 57 | 30576-47-7 | NRPE | C57H100NO8P | 958.38 | | |
| 58 | 30576-84-2 | Spiro[7-oxabicyclo[4.1.0]heptane-3,2'-oxirane], 3',3',6-trimethyl- | C10H16O2 | 168.23 | | |
| 59 | 3057628-14-2 | Anti-MRSA agent 16 | | | | |
| 60 | 3057663-21-2 | 3057663-21-2 | | | | |
| 61 | 3057673-51-2 | 1-(4-Cyclopropyl-2-methoxyphenyl)cyclopropanecarboxylic acid | C14H16O3 | 232.28 | | |
| 62 | 30577-25-4 | Androst-3-en-17-ol, (5α)- (9CI) | C19H30O | 274.44 | | |
| 63 | 3057714-07-2 | Cemsidomide Impurity 23 | | | | |
| 64 | 3057714-10-7 | Cemsidomide Impurity 64 | | | | |
| 65 | 3057714-11-8 | Cemsidomide Impurity 70 | | | | |
| 66 | 3057714-12-9 | Cemsidomide Impurity 55 | | | | |
| 67 | 3057714-49-2 | Cemsidomide Impurity 44 | | | | |
| 68 | 3057714-51-6 | Cemsidomide Impurity 54 | | | | |
| 69 | 3057714-89-0 | Cemsidomide Impurity 10 | | | | |
| 70 | 3057720-61-0 | Allenyl thianthrenium hexafluorophosphate | | | | |
| 71 | 3057728-22-7 | EU 1622-240 | | | | |
| 72 | 3057753-40-6 | NPFF1-R antagonist 1 | | | | |
| 73 | 30578-37-1 | Amezinium mesylate | C12H15N3O5S | 313.33 | 176° (dec) | |
| 74 | 30578-88-2 | Methyl 2,6-dihydroxy-3-nitrobenzoate | C8H7NO6 | 213.14 | | |
| 75 | 3057857-77-6 | 3057857-77-6 | | | | |
| 76 | 30579-21-6 | 1H-Imidazole-1-ethanol,2-[2-(2-methoxyphenyl)ethenyl]-5-nitro-, 1-(4-methylbenzenesulfonate) | C21H22N3O7S | 460.48028 | | |
| 77 | 30579-31-8 | 1H-Imidazole-1-ethanol,2-[2-(3,4-dimethylphenyl)ethenyl]-5-nitro- | C15H17N3O3 | 287.31378 | | |
| 78 | 30579-37-4 | 1H-Imidazole-1-ethanol,2-[2-(4-ethylphenyl)ethenyl]-5-nitro-, 1-(4-methylbenzenesulfonate) | C22H24N3O6S | 458.50746 | | |
| 79 | 30579-42-1 | 1H-Imidazole-1-ethanol,2-[2-[4-(1-methylpropyl)phenyl]ethenyl]-5-nitro- | C17H21N3O3 | 315.36694 | | |
| 80 | 30579-48-7 | 1H-Imidazole-1-ethanol,2-[2-(3-methoxyphenyl)ethenyl]-5-nitro- | C14H15N3O4 | 289.2866 | | |
| 81 | 30579-52-3 | 1H-Imidazole-1-ethanol,5-nitro-2-[2-(3,4,5-trimethoxyphenyl)ethenyl]- | C16H19N3O6 | 349.33856 | | |
| 82 | 30579-53-4 | 1H-Imidazole-1-ethanol,5-nitro-2-[2-(3,4,5-trimethoxyphenyl)ethenyl]-,1-(4-methylbenzenesulfonate) | C23H26N3O9S | 520.53224 | | |
| 83 | 30579-57-8 | 1H-Imidazole-1-ethanol,2-[2-[4-(1-methylethyl)phenyl]ethenyl]-5-nitro- | C16H19N3O3 | 301.34036 | | |
| 84 | 305790-47-0 | 1H-Benzimidazole-1-carboxylic acid, 5-bromo-2,3-dihydro-3-methyl-2-oxo-, 1,1-dimethylethyl ester | C13H15BrN2O3 | 327.17 | | |
| 85 | 305790-48-1 | 6-broMo-1-Methyl-1H-benzo[d]iMidazol-2(3H)-one | C8H7BrN2O | 227.05798 | | |
| 86 | 305790-76-5 | N-(5-Bromo-2-nitrophenyl)-L-proline | C11H11BrN2O4 | 315.12 | | |
| 87 | 305790-78-7 | 2-[(5-bromo-2-nitrophenyl)(methyl)amino]acetic acid | C9H9BrN2O4 | 289.08 | | |
| 88 | 305790-79-8 | 6-Bromo-4-methyl-3,4-dihydroquinoxalin-2(1H)-one | C9H9BrN2O | 241.08 | | |
| 89 | 305791-41-7 | 1-Benzyl-5-pyrrolidin-1-yl-1H-tetrazole | C12H15N5 | 229.28 | | |
| 90 | 305792-46-5 | Methanone,(4-bromophenyl)[1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-,1-(O-ethyloxime) | C28H37BrN4O3 | 557.52238 | | |
| 91 | 305794-65-4 | TERT-BUTYL 4-(DIBROMOMETHYLENE)PIPERIDINE-1-CARBOXYLATE | C11H17Br2NO2 | 355.07 | | |
| 92 | 305794-79-0 | 4,6-dimethyl-pyrimidine-5-carboxylic acid ethyl ester | C9H12N2O2 | 180.2 | | |
| 93 | 305795-89-5 | 5-Bromo-2-chloro-4-fluoroaniline | C6H4BrClFN | 224.46 | | |
| 94 | 305796-69-4 | Hydrazinecarboxylic acid, 2-(1-oxo-2-propynyl)-, 1,1-dimethylethyl ester (9CI) | C8H12N2O3 | 184.19 | | |
| 95 | 305798-02-1 | 2-BROMO-6-(BROMOMETHYL)NAPHTHALENE | C11H8Br2 | 299.989 | | |
| 96 | 305798-03-2 | 2-(6-BroMonaphthalen-2-yl)acetonitrile | C12H8BrN | 246.1 | 118-119 °C | |
| 97 | 3057980-16-9 | [1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-7-oxo-6-[4-(1H-pyrrolo[2,3-c]pyridin-7-ylcarbonyl)-1-piperazinyl]- | | 710.11 | | |
| 98 | 305799-73-9 | 2-(2-AMINO-5-IODOPHENYL)PROPAN-2-OL | C9H12INO | 277.11 | | |
| 99 | 305799-74-0 | 6-(4-CHLOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE | C16H14ClNO2 | 287.74 | | |
| 100 | 305799-82-0 | 5-Bromo-4-methyl-2-thiophenecarboxaldehyde oxime | C6H6BrNOS | 220.08 | | |